About TheraVida
TheraVida is a company based in San Mateo (United States) founded in 2005.. TheraVida has raised $12.5 million across 5 funding rounds from investors including Sanderling Ventures. TheraVida offers products and services including Anhydrix. TheraVida operates in a competitive market with competitors including Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and NEXT Life Sciences, among others.
- Headquarter San Mateo, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Theravida, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.5 M (USD)
in 5 rounds
-
Latest Funding Round
$200 K (USD), Debt – Conventional
Feb 21, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TheraVida
TheraVida offers a comprehensive portfolio of products and services, including Anhydrix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for primary focal hyperhidrosis with improved tolerability.
Funding Insights of TheraVida
TheraVida has successfully raised a total of $12.5M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $200 thousand completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Debt – Conventional — $200,000
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Debt – Conventional - TheraVida | Valuation |
investors |
|
| Jul, 2010 | Amount | Series A - TheraVida | Valuation | Sanderling Ventures |
|
| Jun, 2010 | Amount | Series A - TheraVida | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TheraVida
TheraVida has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Sanderling Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TheraVida
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TheraVida
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theravida Comparisons
Competitors of TheraVida
TheraVida operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Esprit Pharma, Lipella, Regenfro Co, Kissei Pharmaceutical and NEXT Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develop drugs for genitourinary (GU) disorders
|
|
| domain | founded_year | HQ Location |
Lipid-based therapies for common bladder syndromes are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat renal diseases
|
|
| domain | founded_year | HQ Location |
Therapies for renal diseases and urology-related anemia are developed.
|
|
| domain | founded_year | HQ Location |
Male contraception procedures are developed via Vasalgel technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theravida
Frequently Asked Questions about TheraVida
When was TheraVida founded?
TheraVida was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Where is TheraVida located?
TheraVida is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.
Is TheraVida a funded company?
TheraVida is a funded company, having raised a total of $12.5M across 5 funding rounds to date. The company's 1st funding round was a Series A of $8.9M, raised on Jul 05, 2007.
What does TheraVida do?
TheraVida was founded in 2005 in San Mateo, United States, as a clinical-stage biopharma entity. Focus is placed on developing treatments for overactive bladder, urge urinary incontinence, and primary focal hyperhidrosis. The lead product, Tolenix (THVD-201), is designed to minimize dry mouth side effects in overactive bladder therapy. Phase III studies are underway for overactive bladder and urinary incontinence, while Phase II trials address hyperhidrosis.
Who are the top competitors of TheraVida?
TheraVida's top competitors include Lipella, Kissei Pharmaceutical and Regenfro Co.
What products or services does TheraVida offer?
TheraVida offers Anhydrix.
Who are TheraVida's investors?
TheraVida has 1 investor. Key investors include Sanderling Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.